International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 129

Informative Article | Pediatrics | Volume 8 Issue 9, September 2019 | Pages: 1510 - 1511 | India


Herpes Associated Erythema Multiforme: A Diagnostic Dilemma

Palani Rajan, Rajkumar, Arulraj Russelian

Abstract: Erythema multiforme (EM) is an acute muco-cutaneous hypersensitivity reaction which usually affects young adults. Twenty percent of cases occur in children [1]. Erythema multiforme is a self – limiting illness. Herpes Simplex virus is the most common cause of EM, but a few medications like penicillin, barbiturates, NSAIDS, phenothiazines, hydantoins and sulfonamides also have etiological association. Here we report a case of EM with possible etiology of either HSV or drugs to discuss the clinical features, treatment and differentiating features between the two etiologies.

Keywords: ERYTHEMA MULTIFORME, HERPES SIMPLES VIRUS, AMOXYCILLIN, TARGET LESIONS

How to Cite?: Palani Rajan, Rajkumar, Arulraj Russelian, "Herpes Associated Erythema Multiforme: A Diagnostic Dilemma", Volume 8 Issue 9, September 2019, International Journal of Science and Research (IJSR), Pages: 1510-1511, https://www.ijsr.net/getabstract.php?paperid=ART20201464, DOI: https://dx.doi.org/10.21275/ART20201464

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.